Genetic variation in human drug-related genes
Abstract Background Variability in drug efficacy and adverse effects are observed in clinical practice. While the extent of genetic variability in classic pharmacokinetic genes is rather well understood, the role of genetic variation in drug targets is typically less studied. Methods Based on 60,706...
Main Authors: | Charlotta Pauline Irmgard Schärfe, Roman Tremmel, Matthias Schwab, Oliver Kohlbacher, Debora Susan Marks |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado: |
BMC
2017-12-01
|
Series: | Genome Medicine |
Subjects: | |
Acceso en liña: | http://link.springer.com/article/10.1186/s13073-017-0502-5 |
Títulos similares
-
A New Panel-Based Next-Generation Sequencing Method for ADME Genes Reveals Novel Associations of Common and Rare Variants With Expression in a Human Liver Cohort
por: Kathrin Klein, et al.
Publicado: (2019-01-01) -
Pharmacogenomics-Based Detection of Variants Involved in Pain, Anti-inflammatory and Immunomodulating Agents Pathways by Whole Exome Sequencing and Deep in Silico Investigations Revealed Novel Chemical Carcinogenesis and Cancer Risks
por: Alireza Sharafshah, et al.
Publicado: (2025-02-01) -
Characterization of ADME Gene Variation in Colombian Population by Exome Sequencing
por: Daniel Felipe Silgado-Guzmán, et al.
Publicado: (2022-06-01) -
PHARMACOGENETIC TESTING OPPORTUNITIES IN CARDIOLOGY BASED ON EXOME SEQUENCING
por: N. V. Shcherbakova, et al.
Publicado: (2015-09-01) -
Editorial: How pharmacogenomics, epigenetics, and data analysis could improve anticancer treatment?
por: Abdeslam Jaafari, et al.
Publicado: (2022-11-01)